Trademark Search
Owners
Sun Pharmaceutical Industries Limited
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 2,200 MG PER 220 ML (10 MG/ML)
on 08 Dec 2020
Last Applicant/ Owned by
Western Express Highway, Goregaon (E)
Mumbai, Maharashtra
IN
400063
Serial Number
88125549 filed on 20th Sep 2018
Registration Number
6217219 registered on 08th Dec 2020
Correspondent Address
Craig Kuchii, Esq.
SUN PHARMACEUTICAL INDUSTRIES, INC.
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON NJ 08540
Filing Basis
1. intent to use
2. use application currently
Disclaimer
"GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 2,200 MG PER 220 ML (10 MG/ML)"
medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foRead More
medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine
08th Jul 2020
08th Jul 2020
medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
08th Jul 2020
08th Jul 2020
No 88125549
No Service/Collective Mark
No STM-482US
No
No
No
No
No
No
No
No
26.11.13 -
Two rectangles
26.11.21 -
Rectangles that are completely or partially shaded
26.17.09 -
Curved line(s), band(s) or bar(s)
The mark consists of an orange outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with an orange arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in orange, with the words "2,200 mg per 220 mL (10 mg/mL)" in black letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
| Status Date | Action Taken |
|---|---|
| 08th Dec 2020 | REGISTERED-PRINCIPAL REGISTER |
| 04th Nov 2020 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| 03rd Nov 2020 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| 23rd Oct 2020 | TEAS EXTENSION RECEIVED |
| 13th Oct 2020 | STATEMENT OF USE PROCESSING COMPLETE |
| 13th Oct 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| 29th Sep 2020 | USE AMENDMENT FILED |
| 29th Sep 2020 | TEAS STATEMENT OF USE RECEIVED |
| 24th Apr 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| 22nd Apr 2020 | EXTENSION 2 GRANTED |
